Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.50 |
| ▸ | CCR5 | P51681 | 3/20 | 0.50 |
| ▸ | CCR8 | P51685 | 3/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 1/20 | 0.49 |
| ▸ | BCR | P11274 | 1/20 | 0.49 |
| ▸ | METAP2 | P50579 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | ALPL | P05186 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.48 |
| ▸ | ALPG | P10696 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17725300 | 0.90 | CCR1 (0.50) | CCR1CCR5CCR8TRPV1ABL1 | |
| SCHEMBL9958394 | 0.90 | TRPV1 (0.48) | CCR1CCR5CCR8TRPV1ABL1 | |
| SCHEMBL27128937 | 0.89 | TRPV1 (0.45) | CCR1CCR5CCR8TRPV1ABL1 | |
| SCHEMBL10154081 | 0.88 | ABL1 (0.50) | CCR1CCR5CCR8TRPV1ABL1 | |
| SCHEMBL2007559 | 0.86 | CCR1 (0.64) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL13311187 | 0.86 | CCR1 (0.64) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL29660049 | 0.86 | CCR1 (0.64) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL12524042 | 0.84 | TRPV1 (0.64) | CCR1CCR5CCR8TRPV1ABL1 | |
| SCHEMBL15764464 | 0.84 | CCR1 (0.58) | CCR1CCR5CCR8TRPV1ABL1 | |
| SCHEMBL18489879 | 0.84 | CCR1 (0.62) | CCR1CCR5CCR8KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8044013-B2 | Complex of manganese, titanium, nickel, copper, cobalt, iron and ligands | BASF SE (DE) | 2011-10-25 | — | — | US | disclosed |
| US-8044013-B2 | Complex of manganese, titanium, nickel, copper, cobalt, iron and ligands | BASF SE (DE) | 2011-10-25 | — | — | US | disclosed |
| US-8044013-B2 | Complex of manganese, titanium, nickel, copper, cobalt, iron and ligands | BASF SE (DE) | 2011-10-25 | — | — | US | disclosed |
| US-7692004-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| US-7692004-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| US-7692004-B2 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-04-06 | — | — | US | disclosed |
| US-20090189119-A1 | Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202 | WIEPRECHT TORSTEN | 2009-07-30 | — | — | US | disclosed |
| US-20090189119-A1 | Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202 | WIEPRECHT TORSTEN | 2009-07-30 | — | — | US | disclosed |
| US-20090189119-A1 | Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202 | WIEPRECHT TORSTEN | 2009-07-30 | — | — | US | disclosed |
| US-20090068282-A1 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORPORATION | 2009-03-12 | — | — | US | disclosed |
| US-20060264633-A1 | Use of metal complex compounds as oxidation catalysts | SCHLINGLOFF GUNTHER | 2006-11-23 | — | — | US | disclosed |
| EP-1703977-A1 | USE OF A COMPOSITION COMPRISING METAL COMPLEX COMPOUNDS AND POLYPHOSPHONATES AS CATALYSTS FOR OXIDATIONS | Ciba SC Holding AG (CH) | 2006-09-27 | — | — | EP | disclosed |
| EP-1383857-B1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA SC HOLDING AG (CH) | 2006-05-31 | — | — | EP | disclosed |
| US-20060019853-A1 | Use of metal complex compounds as catalysts for oxidation using molecular oxygen or air | CIBA SPECIALTY CHEMICALS CORP. | 2006-01-26 | — | — | US | disclosed |
| WO-2005068075-A1 | USE OF A COMPOSITION COMPRISING METAL COMPLEX COMPOUNDS AND POLYPHOSPHONATES AS CATALYSTS FOR OXIDATIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-07-28 | — | — | WO | disclosed |
| EP-1556468-A1 | USE OF METAL COMPLEX COMPOUNDS AS CATALYSTS FOR OXIDATION USING MOLECULAR OXYGEN OR AIR | Ciba SC Holding AG (CH) | 2005-07-27 | — | — | EP | disclosed |
| US-20040142843-A1 | Use of metal complex compounds as oxidation catalysts | CIBA SPECIALTY CHEMICALS CORP. | 2004-07-22 | — | — | US | disclosed |
| WO-2004039933-A1 | USE OF METAL COMPLEX COMPOUNDS AS CATALYSTS FOR OXIDATION USING MOLECULAR OXYGEN OR AIR | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-05-13 | — | — | WO | disclosed |
| EP-1383857-A2 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | Ciba SC Holding AG (CH) | 2004-01-28 | — | — | EP | disclosed |
| WO-2002088289-A2 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264633-A1 | Use of metal complex compounds as oxidation catalysts | MICOS13, MLX, SOD1 | CCR1 1360/4885CCR5 676/4885CCR8 984/4885 |
| US-20060019853-A1 | Use of metal complex compounds as catalysts for oxidation using molecular oxygen or air | COX14, MICOS13, OR10J3 | CCR1 1334/4885CCR5 858/4885CCR8 883/4885 |
| US-20090068282-A1 | Use of metal complex compounds as oxidation catalysts | MICOS13, MLX, SOD1 | CCR1 1334/4885CCR5 641/4885CCR8 930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.